210 related articles for article (PubMed ID: 4364363)
1. Blocking antibodies and enhancement.
Heppner GH
Ser Haematol; 1972; 5(4):41-66. PubMed ID: 4364363
[No Abstract] [Full Text] [Related]
2. Immunology of virus-induced tumours.
Sjögren HO
Mod Trends Med Virol; 1967; 1(0):207-22. PubMed ID: 4366129
[No Abstract] [Full Text] [Related]
3. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
Law LW
Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
[No Abstract] [Full Text] [Related]
4. [The state of transplantation immunology from an experimental viewpoint].
von Broen B
Z Exp Chir; 1975; 8(4):198-214. PubMed ID: 162019
[No Abstract] [Full Text] [Related]
5. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
Kieler J
Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
[No Abstract] [Full Text] [Related]
6. Enhancement phenomenon.
Petrányi GG
Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
[No Abstract] [Full Text] [Related]
7. Immunological enhancement, blocking factors, and tolerance to tumours, transplants and foetuses.
Halliday WJ
Aust N Z J Med; 1972 Nov; 2(4):416-21. PubMed ID: 4572903
[No Abstract] [Full Text] [Related]
8. Mechanisms of immunologic enhancement.
Amos DB; Cohen I; Klein WJ
Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
[No Abstract] [Full Text] [Related]
9. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
Bach ML; Bach FH; Zoschke DC
Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
[No Abstract] [Full Text] [Related]
10. [Basic principles of transplantation immunology].
Land W; Brendel W
Fortschr Kiefer Gesichtschir; 1976; 20():1-10. PubMed ID: 131100
[No Abstract] [Full Text] [Related]
11. Lymphocyte inhibition by mammary tumor virus in patients with breast cancer.
Moulton A; Gerfo PL; Suciu-Foca N; Silverstein G
J Surg Res; 1974 Jun; 16(6):592-8. PubMed ID: 4366357
[No Abstract] [Full Text] [Related]
12. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
Weiland E; Weiland F
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
[No Abstract] [Full Text] [Related]
13. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
Lamon EW; Gatti RA; Kiessling R; Fenyö EM
Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
[TBL] [Abstract][Full Text] [Related]
14. Problems and prospects in surgical immunology II.
Häyry P
Med Biol; 1976 Apr; 54(2):73-107. PubMed ID: 131887
[No Abstract] [Full Text] [Related]
15. Testing immunological responses to experimental allografts.
Hamburger J; Debray-Sachs M; Dimitriu A; Dy M; Caraux J
Transplant Proc; 1974 Dec; 6(4 Suppl 1):85-91. PubMed ID: 4280168
[No Abstract] [Full Text] [Related]
16. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
Egusa K
Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
[No Abstract] [Full Text] [Related]
17. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
18. Humoral responses in tumor immunity: review of experimental findings.
Mizejewski GJ
Am J Med Sci; 1973 Nov; 266(5):359-69. PubMed ID: 4586922
[No Abstract] [Full Text] [Related]
19. Relationship between blocking and unblocking activity and tumor growth in vivo.
Sjögren HO; Bansal SC
Natl Cancer Inst Monogr; 1972 Dec; 35():231-5. PubMed ID: 4349148
[No Abstract] [Full Text] [Related]
20. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
McCoy JL; Ting RC; McCoy NT; Reisher JI; Chan SP; Law LW
Int J Cancer; 1974 May; 13(5):731-41. PubMed ID: 4367343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
